 | Characterising anxiety in Parkinson's disease: A psycholinguistic and psychophysiology study comparing to anxious older adults, 2013 - 2013
Funded by: Royal Brisbane & Women'S Hospital Foundation |
 | Improving diagnostic methods of anxiety disorders in Parkinson's disease: Phase 2, 2012 - 2013
Funded by: Royal Brisbane & Women'S Hospital Foundation |
 | Psychosis Research, 2012 - 2012
Funded by: Office of the Deputy Vice Chancellor (Research) |
 | Clinical Study No. DRI10734, [......] tolerability of SAR110894D at the doses of 0.5 mg, 2 mg, and 5 mg/day for 24 weeks in patients with mild to moderate Alzheimer's Disease on stable donepezil, 2011 - 2013
Funded by: Sanofi-Aventis Australia Pty Ltd |
 | Improving anxiety assessment and management in people with dementia: Validation of an informant measure and pilot testing of a multi-component behavioural intervention, 2011 - 2013
Funded by: Queensland University of Technology |
 | Improving diagnostic methods of anxiety disorders in Parkinson's disease, 2011 - 2013
Funded by: Royal Brisbane & Women'S Hospital Foundation |
 | Measures of cholinergic basal forebrain degeneration as an early screen for Alzheimer's disease, 2011 - 2013
Funded by: ANZ Trustees Limited |
 | Novel methods for early detection of anxiety in Parkinson's disease, 2011 - 2013
Funded by: Parkinson's Queensland Inc |
 | The Pathophysiology of Excitotoxicity in Alzheimer's Disease, 2011 - 2013
Funded by: ANZ Trustees Limited |
 | CONCERT PLUS: An Open-Label Extension of the CONCERT Protocol (DIM18) Evaluating Dimebin (Latrepirdine) in Patients with Alzheimer's Disease, 2010 - 2013
Funded by: Novotech (Australia) Pty Ltd |
 | Integrated brain imaging and electrophysiology for clinical neurosciences, 2010 - 2010
Funded by: National Health and Medical Research Council, University of Queensland, Queensland Institute of Medical Research, University of Queensland |
 | MBF Research Support Award for research into Psychiatry and Clinical Neuroscience, 2010 - 2012
Funded by: Mayne Bequest Fund |
 | Taking the 50+ Registry into the next decade: Establishing community databases for ageing research at UQ, 2010 - 2010
Funded by: University Of Queensland, National Health and Medical Research Council, University of Queensland, University of Queensland, University of Queensland |
 | A multicentre randomized clinical trial of physical activity for treatment of patients with Alzheimer's Disease - Fitness for the Ageing Brain Study II - FABS II (NHMRC Project admin by Uni Melb), 2009 - 2011
Funded by: University of Melbourne |
 | CONCERT: A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-Blind Twelve-Month Safety and Efficacy Study evaluating Dimebon in Patients with Mild-to-moderate Alzheimer Disease on Donepezil, 2009 - 2011
Funded by: Novotech (Australia) Pty Ltd |
 | Development of quality indicators for an accreditation and quality framework for dementia care in acute hospitals, 2009 - 2011
Funded by: The JO and JR Wicking Trust |
 | Validation of a competency assessment method for persons with dementia, 2009 - 2012
Funded by: National Health And Medical Research Council |
 | A randomised single-blind placebo-controlled study to investigate the safety tolerability immunogenicity pharmacokinetics and pharmacodynamics of intravenous infusion of GSK933776 in Alheimers patient, 2008 - 2009
Funded by: Glaxo Smith Kline Australia Pty Ltd |
 | An efficacy study of a cognitive-communicative intervention to improve transition to residential care in dementia., 2008 - 2012
Funded by: National Health And Medical Research Council |
 | Clinical outcomes, staff and carer perceptions of acute hospitalisation of patients with dementia, 2008 - 2011
Funded by: National Health And Medical Research Council |
 | Open Label Extension Study of 23mg Donepezil Sustained Release in Patients with Moderate to Severe Alzheimer?s Disease (E2020-G000-328), 2008 - 2010
Funded by: ICON Clinical Research Pty Limited |
 | Study AZ3110866: A fixed dose study of SB-742457 versus placebo when added to existing Donepezil treatment in subjects with mild-to-moderate Alzheimer's disease, 2008 - 2009
Funded by: Glaxo Smith Kline Australia Pty Ltd |
 | Double-Blind, Parallel-Group Comparison of 23mg Donepezil Sustained Release to 10mg Donepezil Immediate Release in Patients with Moderate to Severe Alzheimer's Disease, 2007 - 2009
Funded by: ICON Clinical Research Pty Limited |
 | Enhancing transition from home to residential care in dementia, 2007 - 2010
Funded by: The JO and JR Wicking Trust |
 | Prospective study of the emergence of syndromal and sub-syndromal anxiety and depression during cognitive decline., 2007 - 2010
Funded by: National Health And Medical Research Council |
| Page: | 1 2
|
| Select all records |
| |